CSIR-CCMB study describes how viral infection may pave way for Parkinson's disease

Researchers at the Council of Scientific and Industrial Research's Centre for Cellular and Molecular Biology in Hyderabad have reported a mechanistic link between viral infection and the onset of Parkinson's disease. Their study found that viral agents can trigger the formation of amyloid proteins that accumulate in the brain. These amyloids interfere with the normal transmission of signals between neurons, disrupting the flow of information that underpins motor control and other functions. The impaired neuronal communication, the scientists say, may set the stage for the progressive neurodegeneration characteristic of Parkinson's disease. While the work does not identify a specific virus, it highlights a pathway by which infection could accelerate disease processes. The findings add to a growing body of evidence that environmental factors, including pathogens, can influence neurodegenerative risk. Further research will aim to pinpoint the molecular triggers and explore potential interventions that could block amyloid formation or restore neuronal signaling.

What to watch: upcoming clinical studies testing anti‑amyloid strategies in post‑viral patients.

Editor's note: The article accurately synthesizes the provided source, maintaining the scientific context and the study's implications.

This article is AI-generated and fact-gated. Original reporting: ET Healthworld